Enhanced blood pressure variability in a high cardiovascular risk group of african Americans: FIT4Life Study

Journal of the American Society of Hypertension

Volumn 4, Issue 4, 2010, Pages 187-195

  Veerabhadrappa, Praveen ^a   Diaz, Keith M ^a   Feairheller, Deborah L ^a   Sturgeon, Kathleen M ^a   Williamson, Sheara ^a   Crabbe, Deborah L ^b   Kashem, Abul ^b   Ahrensfield, Debra ^b   Brown, Michael D ^a,b  

^a TEMPLE UNIVERSITY   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

African Americans; Ambulatory blood pressure monitoring; Blood pressure variability; High sensitivity C reactive protein; Inflammation; Tumor necrosis factor alpha; White blood cells

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; CIRCADIAN RHYTHM; DIASTOLE; FEMALE; HEALTH STATUS; HUMAN; LEUKOCYTE COUNT; MALE; MIDDLE AGED; NEGRO; PHYSIOLOGY; SYSTOLE; UNITED STATES;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; BIOLOGICAL MARKERS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CIRCADIAN RHYTHM; DIASTOLE; FEMALE; HEALTH STATUS; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PHILADELPHIA; SYSTOLE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77957719578     PISSN: 19331711     EISSN: 18787436     Source Type: Journal    
DOI: 10.1016/j.jash.2010.04.005     Document Type: Article

References (39)

1. Francis CK. Hypertension, cardiac disease, and compliance in minority patients. Am J Med 1991;91:29S-36S.
2. Sowers JR, Ferdinand KC, Bakris GL, Douglas JG. Hypertension-related disease in African Americans. Factors underlying disparities in illness and its outcome. Postgrad Med 2002;112:24-30, 33.
3. Ferdinand KC. Introduction: management of hypertension and cardiovascular risk factors in African Americans. J Clin Hypertens (Greenwich) 2003;5(1 Suppl 1):3-4.
4. Fiscella K, Holt K. Racial disparity in hypertension control: tallying the death toll. Ann Fam Med 2008;6: 497-502.
5. Libby P. Coronary artery injury and the biology of atherosclerosis: inflammation, thrombosis, and stabilization. Am J Cardiol 2000 Oct 19;86:3J-8J.
6. Libby P, Ridker PM. Inflammation and atherosclerosis: role of C-reactive protein in risk assessment. Am J Med 2004;116(Suppl 6A):9S-16S.
7. Hernandez-Presa M, Bustos C, Ortego M, Tunon J, Renedo G, Ruiz-Ortega M, et al. Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation 1997;95:1532-41.
8. Schillaci G, Pirro M, Gemelli F, Pasqualini L, Vaudo G, Marchesi S, et al. Increased C-reactive protein concentrations in never-treated hypertension: the role of systolic and pulse pressures. J Hypertens 2003;21: 1841-6.
9. Chrysohoou C, Pitsavos C, Panagiotakos DB, Skoumas J, Stefanadis C. Association between prehypertension status and inflammatory markers related to atherosclerotic disease: the ATTICA Study. Am J Hypertens 2004;17:568-73.
10. Lakoski SG, Cushman M, Palmas W, Blumenthal R, D'Agostino RB Jr, Herrington DM. The relationship between blood pressure and C-reactive protein in the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol 2005;46:1869-74.
11. Kalinowski L, Dobrucki IT, Malinski T. Race-specific differences in endothelial function: predisposition of African Americans to vascular diseases. Circulation 2004;109:2511-7.
12. Klag MJ. Hypertension in African Americans. Ann Epidemiol 1996;6:171-2.
13. Bowman SA. Socioeconomic characteristics, dietary and lifestyle patterns, and health and weight status of older adults in NHANES, 1999-2002: a comparison of Caucasians and African Americans. J Nutr Elder 2009;28:30-46.
14. Choi JB, Hong S, Nelesen R, Bardwell WA, Natarajan L, Schubert C, et al. Age and ethnicity differences in short-term heart-rate variability. Psychosom Med 2006;68:421-6.
15. Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 2006;6:508-19.
16. Musini VM, Wright JM. Factors affecting blood pressure variability: lessons learned from two systematic reviews of randomized controlled trials. PLoS One 2009;4:e5673.
17. Parati G, Lantelme P. Blood pressure variability, target organ damage and cardiovascular events. J Hypertens 2002;20:1725-9.
18. Tatasciore A, Zimarino M, Renda G, Zurro M, Soccio M, Prontera C, et al. Awake blood pressure variability, inflammatory markers and target organ damage in newly diagnosed hypertension. Hypertension Res 2008;31:2137-46.
19. Tatasciore A, Renda G, Zimarino M, Soccio M, Bilo G, Parati G, et al. Awake systolic blood pressure variability correlates with target-organ damage in hypertensive subjects. Hypertension 2007;50:325-32.
20. Mena L, Pintos S, Queipo NV, Aizpurua JA, Maestre G, Sulbaran T. A reliable index for the prognostic significance of blood pressure variability. J Hypertens 2005; 23:505-11.
21. Pearson TA, Mensah GA, Hong Y, Smith SC Jr. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: overview. Circulation 2004;110:e543-4.
22. Frattola A, Parati G, Cuspidi C, Albini F, Mancia G. Prognostic value of 24-hour blood pressure variability. J Hypertens 199;11:1133-7.
23. Pierdomenico SD, Di NM, Esposito AL, Di MR, Ballone E, Lapenna D, et al. Prognostic value of different indices of blood pressure variability in hypertensive patients. Am J Hypertens 2009;22:842-7.
24. Parati G, Bilo G, Vettorello M, Groppelli A, Maronati A, Tortorici E, et al. Assessment of overall blood pressure variability and its different components. Blood Press Monit 2003;8:155-9.
25. Hansen TW, Li Y, Staessen JA. Blood pressure variability remains an elusive predictor of cardiovascular outcome. Am J Hypertens 2009;22:3-4.
26. Chobanian AV, Bakris GL, Black HR. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-52.
27. Parati G. Blood pressure variability: its measurement and significance in hypertension. J Hypertens Suppl 2005;23:S19.
28. Parati G, Rizzoni D. Assessing the prognostic relevance of blood pressure variability: discrepant information from different indices. J Hypertens 2005;23:483-6.
29. Mancia G, Bombelli M, Facchetti R, Madotto F, Corrao G, Trevano FQ, et al. Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study. Hypertension 2007;49:1265-70.
30. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003;111:1805-12.
31. Sesso HD, Buring JE, Rifai N. C-reactive protein and the risk of developing hypertension. JAMA 2003;290: 2945-51.
32. Lakoski SG, Cushman M, Palmas W, Blumenthal R, D'Agostino RB Jr, Herrington DM. The relationship between blood pressure and C-reactive protein in the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol 2005;46:1869-74.
33. Intengan HD, Schiffrin EL. Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension 2001;38:581-7.
34. Engstrom G, Janzon L, Berglund G. Blood pressure increase and incidence of hypertension in relation to inflammation-sensitive plasma proteins. Arterioscler Thromb Vasc Biol 2002;22:2054-8.
35. Chae CU, Lee RT, Rifai N, Ridker PM. Blood pressure and inflammation in apparently healthy men. Hypertension 2001;38:399-403.
36. Bautista LE, Atwood JE, O'Malley PG. Association between C-reactive protein and hypertension in healthy middle-aged men and women. Coron Artery Dis 2004; 15:331-6.
37. Abramson JL, Lewis C, Murrah NV. Relation of C-reactive protein and tumor necrosis factor-alpha to ambulatory blood pressure variability in healthy adults. Am J Cardiol 2006;98:649-52.
38. Kim KI, Lee JH, Chang HJ, Cho YS, Youn TJ, Chung WY, et al. Association between blood pressure variability and inflammatory marker in hypertensive patients. Circ J 2008;72:293-8.
39. Blaber AP, Bondar RL, Freeman R. Coarse graining spectral analysis of HR and BP variability in patients with autonomic failure. Am J Physiol 1996;271(4 Pt 2): H1555-64.